New lupus skin rash pill enters final testing phase
NCT ID NCT07355218
Summary
This study aims to see if a new pill called enpatoran can safely reduce skin rashes and symptoms in people with lupus. About 202 participants with active lupus skin disease will take either the drug or a placebo pill for 24 weeks while continuing their standard lupus medications. Researchers will measure changes in skin rash severity, itch, and overall disease activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Darmstadt, Germany
Conditions
Explore the condition pages connected to this study.